Private Advisor Group LLC Lowers Holdings in SPDR S&P Biotech ETF $XBI

Private Advisor Group LLC trimmed its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 26.8% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 32,456 shares of the exchange traded fund’s stock after selling 11,904 shares during the quarter. Private Advisor Group LLC’s holdings in SPDR S&P Biotech ETF were worth $4,146,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in the company. Avoro Capital Advisors LLC acquired a new stake in shares of SPDR S&P Biotech ETF in the fourth quarter valued at about $256,053,000. Wells Fargo & Company MN lifted its stake in SPDR S&P Biotech ETF by 75.7% in the 4th quarter. Wells Fargo & Company MN now owns 3,566,265 shares of the exchange traded fund’s stock valued at $434,835,000 after buying an additional 1,536,122 shares in the last quarter. OMERS ADMINISTRATION Corp boosted its holdings in SPDR S&P Biotech ETF by 42,425.2% in the 4th quarter. OMERS ADMINISTRATION Corp now owns 1,190,707 shares of the exchange traded fund’s stock worth $145,147,000 after buying an additional 1,187,907 shares during the last quarter. Morgan Stanley increased its stake in SPDR S&P Biotech ETF by 8.3% during the 4th quarter. Morgan Stanley now owns 11,491,683 shares of the exchange traded fund’s stock worth $1,401,181,000 after buying an additional 882,718 shares in the last quarter. Finally, Assetmark Inc. increased its stake in SPDR S&P Biotech ETF by 1,042,265.6% during the 4th quarter. Assetmark Inc. now owns 635,843 shares of the exchange traded fund’s stock worth $77,528,000 after buying an additional 635,782 shares in the last quarter.

SPDR S&P Biotech ETF Price Performance

Shares of SPDR S&P Biotech ETF stock opened at $162.97 on Thursday. The business has a 50 day simple moving average of $139.15 and a two-hundred day simple moving average of $130.89. SPDR S&P Biotech ETF has a 12 month low of $84.39 and a 12 month high of $164.35. The stock has a market capitalization of $11.10 billion, a P/E ratio of 11.47 and a beta of 0.82.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.